Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 13-Nov-06 4:39 PM View:  | Krishnan Suma Vice President, Product Dev. | New River Pharmaceuticals Inc (NRPH) | 10-Nov-06 | Market Sale | 31,000 | $48.23 | $1,495,120.00 | (97%) 32.0K to 1.0K | |
| 13-Nov-06 4:41 PM View: | Krishnan Krish S COO, CFO and Secretary Director | New River Pharmaceuticals Inc (NRPH) | 10-Nov-06 | Market Option Sale Duplicate | 4,217 | $48.23 | $203,385.00 | (12%) 36.22K to 32.0K | |
| 13-Nov-06 4:41 PM View: | Krishnan Krish S COO, CFO and Secretary Director | New River Pharmaceuticals Inc (NRPH) | 10-Nov-06 | Market Sale Duplicate | 31,000 | $48.23 | $1,495,120.00 | (97%) 32.0K to 1.0K | |
| 13-Nov-06 4:37 PM View: | Kirk Randal J Chairman, President and CEO Director 10% Owner | New River Pharmaceuticals Inc (NRPH) | 10-Nov-06 | Market Sale | 391,305 | $48.23 | $18,872,500.00 | (2%) 19.0M to 18.61M | |
| 13-Nov-06 4:39 PM View: | Krishnan Suma Vice President, Product Dev. | New River Pharmaceuticals Inc (NRPH) | 10-Nov-06 | Market Option Sale | 4,217 | $48.23 | $203,385.00 | (12%) 36.22K to 32.0K | |
| 13-Nov-06 4:39 PM View: | Krishnan Suma Vice President, Product Dev. | New River Pharmaceuticals Inc (NRPH) | 09-Nov-06 | Option Exercise | 59,000 | $2.45 | $144,334.00 | 184% 32.0K to 91.0K | |
| 13-Nov-06 4:37 PM View: | Kirk Randal J Chairman, President and CEO Director 10% Owner | New River Pharmaceuticals Inc (NRPH) | 09-Nov-06 | Market Sale | 608,695 | $49.01 | $29,832,500.00 | (3%) 19.61M to 19.0M | |
| 13-Nov-06 4:41 PM View: | Krishnan Krish S COO, CFO and Secretary Director | New River Pharmaceuticals Inc (NRPH) | 09-Nov-06 | Option Exercise Duplicate | 59,000 | $2.45 | $144,334.00 | 184% 32.0K to 91.0K | |
| 13-Nov-06 4:39 PM View: | Krishnan Suma Vice President, Product Dev. | New River Pharmaceuticals Inc (NRPH) | 09-Nov-06 | Market Option Sale | 54,783 | $49.01 | $2,684,950.00 | (60%) 91.0K to 36.22K | |
| 13-Nov-06 4:41 PM View: | Krishnan Krish S COO, CFO and Secretary Director | New River Pharmaceuticals Inc (NRPH) | 09-Nov-06 | Market Option Sale Duplicate | 54,783 | $49.01 | $2,684,950.00 | (60%) 91.0K to 36.22K | |
| 26-Oct-06 2:56 PM View: | Krishnan Krish S COO, CFO and Secretary Director | New River Pharmaceuticals Inc (NRPH) | 25-Oct-06 | Disposition Duplicate | 63,900 | $48.65 | $3,108,740.00 | (67%) 95.9K to 32.0K | |
| 26-Oct-06 2:54 PM View: | Krishnan Suma Vice President, Product Dev. | New River Pharmaceuticals Inc (NRPH) | 25-Oct-06 | Disposition | 63,900 | $48.65 | $3,108,740.00 | (67%) 95.9K to 32.0K | |
| 26-Oct-06 2:54 PM View: | Krishnan Suma Vice President, Product Dev. | New River Pharmaceuticals Inc (NRPH) | 25-Oct-06 | Option Exercise | 63,900 | $12.00 | $766,800.00 | 200% 32.0K to 95.9K | |
| 26-Oct-06 2:56 PM View: | Krishnan Krish S COO, CFO and Secretary Director | New River Pharmaceuticals Inc (NRPH) | 25-Oct-06 | Option Exercise Duplicate | 63,900 | $12.00 | $766,800.00 | 200% 32.0K to 95.9K | |
| 19-May-06 5:13 PM View: | Krishnan Suma Vice President, Product Dev. Director | New River Pharmaceuticals Inc (NRPH) | 18-May-06 | Market Option Sale (Planned) | 30,000 | $29.21 | $876,204.00 | (48%) 62.0K to 32.0K | |
| 19-May-06 5:15 PM View: | Krishnan Krish S COO, CFO and Secretary Director | New River Pharmaceuticals Inc (NRPH) | 18-May-06 | Market Option Sale (Planned) Duplicate | 30,000 | $29.21 | $876,204.00 | (48%) 62.0K to 32.0K | |
| 19-May-06 5:15 PM View: | Krishnan Krish S COO, CFO and Secretary Director | New River Pharmaceuticals Inc (NRPH) | 18-May-06 | Option Exercise Duplicate | 30,000 | $3.94 | $118,166.00 | 94% 32.0K to 62.0K | |
| 19-May-06 5:13 PM View: | Krishnan Suma Vice President, Product Dev. Director | New River Pharmaceuticals Inc (NRPH) | 18-May-06 | Option Exercise | 30,000 | $3.94 | $118,166.00 | 94% 32.0K to 62.0K | |
| 21-Apr-06 4:43 PM View: | Kirk Randal J Chairman, President and CEO Director 10% Owner | New River Pharmaceuticals Inc (NRPH) | 19-Apr-06 | Market Sale | 103,116 | $33.50 | $3,454,390.00 | (< 1%) 20.5M to 20.39M | |
| 21-Apr-06 4:43 PM View: | Kirk Randal J Chairman, President and CEO Director 10% Owner | New River Pharmaceuticals Inc (NRPH) | 19-Apr-06 | Market Sale | 783,884 | $33.50 | $26,260,100.00 | (4%) 20.39M to 19.61M | |
| 23-Mar-06 3:10 PM View: | Kirk Randal J Chairman, President and CEO Director 10% Owner | New River Pharmaceuticals Inc (NRPH) | 22-Mar-06 | Option Exercise | 10,000 | $3.33 | $33,300.00 | < 1% 20.49M to 20.5M | |
| 22-Mar-06 5:08 PM View: | Krishnan Krish S COO, CFO and Secretary Director | New River Pharmaceuticals Inc (NRPH) | 20-Mar-06 | Market Option Sale (Planned) Duplicate | 30,000 | $30.86 | $925,737.00 | (48%) 62.0K to 32.0K | |
| 22-Mar-06 5:08 PM View: | Krishnan Krish S COO, CFO and Secretary Director | New River Pharmaceuticals Inc (NRPH) | 20-Mar-06 | Option Exercise Duplicate | 30,000 | $1.25 | $37,500.00 | 94% 32.0K to 62.0K | |
| 22-Mar-06 5:09 PM View: | Krishnan Suma Vice President, Product Dev. | New River Pharmaceuticals Inc (NRPH) | 20-Mar-06 | Option Exercise | 30,000 | $1.25 | $37,500.00 | 94% 32.0K to 62.0K | |
| 22-Mar-06 5:09 PM View: | Krishnan Suma Vice President, Product Dev. | New River Pharmaceuticals Inc (NRPH) | 20-Mar-06 | Market Option Sale (Planned) | 30,000 | $30.86 | $925,737.00 | (48%) 62.0K to 32.0K | |
| 15-Feb-06 10:00 PM View: | Kirk Randal J Chairman, President and CEO Director 10% Owner | New River Pharmaceuticals Inc (NRPH) | 14-Feb-06 | Market Sale | 128,377 | $30.00 | $3,851,310.00 | (< 1%) 20.62M to 20.49M | |
| 15-Feb-06 4:20 PM View: | Krishnan Krish S COO, CFO and Secretary Director | New River Pharmaceuticals Inc (NRPH) | 14-Feb-06 | Market Option Sale | 82,536 | $30.00 | $2,476,080.00 | (72%) 114.54K to 32.0K | |
| 15-Feb-06 10:00 PM View: | Kirk Randal J Chairman, President and CEO Director 10% Owner | New River Pharmaceuticals Inc (NRPH) | 14-Feb-06 | Market Sale | 16,887 | $30.00 | $506,610.00 | (< 1%) 20.63M to 20.62M | |
| 15-Feb-06 4:20 PM View: | Krishnan Krish S COO, CFO and Secretary Director | New River Pharmaceuticals Inc (NRPH) | 14-Feb-06 | Option Exercise | 82,536 | $1.92 | $158,170.00 | 258% 32.0K to 114.54K | |
| 15-Feb-06 10:00 PM View: | Krishnan Suma Vice President, Product Dev. | New River Pharmaceuticals Inc (NRPH) | 14-Feb-06 | Option Exercise Duplicate | 82,536 | $1.92 | $158,170.00 | 258% 32.0K to 114.54K | |
| 15-Feb-06 10:00 PM View: | Krishnan Suma Vice President, Product Dev. | New River Pharmaceuticals Inc (NRPH) | 14-Feb-06 | Market Option Sale Duplicate | 82,536 | $30.00 | $2,476,080.00 | (72%) 114.54K to 32.0K | |
| 15-Feb-06 10:00 PM View: | Kirk Randal J Chairman, President and CEO Director 10% Owner | New River Pharmaceuticals Inc (NRPH) | 13-Feb-06 | Market Sale | 3,573 | $30.12 | $107,607.00 | (< 1%) 20.66M to 20.66M | |
| 15-Feb-06 4:20 PM View: | Krishnan Krish S COO, CFO and Secretary Director | New River Pharmaceuticals Inc (NRPH) | 13-Feb-06 | Market Option Sale | 17,464 | $30.12 | $525,958.00 | (35%) 49.46K to 32.0K | |
| 15-Feb-06 10:00 PM View: | Kirk Randal J Chairman, President and CEO Director 10% Owner | New River Pharmaceuticals Inc (NRPH) | 13-Feb-06 | Market Sale | 27,163 | $30.12 | $818,060.00 | (< 1%) 20.66M to 20.63M | |
| 15-Feb-06 4:20 PM View: | Krishnan Krish S COO, CFO and Secretary Director | New River Pharmaceuticals Inc (NRPH) | 13-Feb-06 | Option Exercise | 17,464 | $1.25 | $21,830.00 | 55% 32.0K to 49.46K | |
| 15-Feb-06 10:00 PM View: | Krishnan Suma Vice President, Product Dev. | New River Pharmaceuticals Inc (NRPH) | 13-Feb-06 | Option Exercise Duplicate | 17,464 | $1.25 | $21,830.00 | 55% 32.0K to 49.46K | |
| 15-Feb-06 10:00 PM View: | Krishnan Suma Vice President, Product Dev. | New River Pharmaceuticals Inc (NRPH) | 13-Feb-06 | Market Option Sale Duplicate | 17,464 | $30.12 | $525,958.00 | (35%) 49.46K to 32.0K | |
| 20-Dec-05 11:16 AM View: | Kirk Randal J Chairman, President and CEO Director 10% Owner | New River Pharmaceuticals Inc (NRPH) | 19-Dec-05 | Market Sale (Planned) | 7,500 | $49.17 | $368,750.00 | (< 1%) 10.34M to 10.33M | |
| 16-Dec-05 5:03 PM View: | Kirk Randal J Chairman, President and CEO Director 10% Owner | New River Pharmaceuticals Inc (NRPH) | 16-Dec-05 | Market Sale (Planned) | 91,800 | $48.80 | $4,480,020.00 | (< 1%) 10.92M to 10.83M | |
| 16-Dec-05 5:03 PM View: | Kirk Randal J Chairman, President and CEO Director 10% Owner | New River Pharmaceuticals Inc (NRPH) | 15-Dec-05 | Market Sale (Planned) | 3,000 | $49.50 | $148,500.00 | (< 1%) 10.92M to 10.92M | |
| 16-Dec-05 5:03 PM View: | Kirk Randal J Chairman, President and CEO Director 10% Owner | New River Pharmaceuticals Inc (NRPH) | 14-Dec-05 | Market Sale (Planned) | 285,200 | $47.46 | $13,535,000.00 | (3%) 11.21M to 10.92M | |
| 13-Dec-05 4:47 PM View: | Kirk Randal J Chairman, President and CEO Director 10% Owner | New River Pharmaceuticals Inc (NRPH) | 13-Dec-05 | Market Sale (Planned) | 20,000 | $46.46 | $929,120.00 | (< 1%) 11.23M to 11.21M | |
| 13-Dec-05 4:47 PM View: | Kirk Randal J Chairman, President and CEO Director 10% Owner | New River Pharmaceuticals Inc (NRPH) | 12-Dec-05 | Market Sale (Planned) | 5,000 | $48.45 | $242,236.00 | (< 1%) 11.23M to 11.23M | |
| 13-Dec-05 4:47 PM View: | Kirk Randal J Chairman, President and CEO Director 10% Owner | New River Pharmaceuticals Inc (NRPH) | 09-Dec-05 | Market Sale (Planned) | 10,000 | $49.03 | $490,338.00 | (< 1%) 11.24M to 11.23M | |
| 07-Dec-05 1:59 PM View: | Kirk Randal J Chairman, President and CEO Director 10% Owner | New River Pharmaceuticals Inc (NRPH) | 06-Dec-05 | Market Sale (Planned) | 28,200 | $48.87 | $1,378,130.00 | (< 1%) 11.27M to 11.24M | |
| 07-Dec-05 1:59 PM View: | Kirk Randal J Chairman, President and CEO Director 10% Owner | New River Pharmaceuticals Inc (NRPH) | 05-Dec-05 | Market Sale (Planned) | 23,800 | $49.13 | $1,169,290.00 | (< 1%) 11.3M to 11.27M | |
| 22-Nov-05 6:22 PM View: | Krishnan Krish S COO, CFO and Secretary Director | New River Pharmaceuticals Inc (NRPH) | 22-Nov-05 | Market Sale (Planned) Duplicate | 3,000 | $51.34 | $154,034.00 | (16%) 19.0K to 16.0K | |
| 22-Nov-05 5:59 PM View: | Barlow David S Director | New River Pharmaceuticals Inc (NRPH) | 22-Nov-05 | Option Exercise | 5,000 | $6.67 | $33,350.00 | 100% 0 to 5.0K | |
| 22-Nov-05 6:22 PM View: | Krishnan Krish S COO, CFO and Secretary Director | New River Pharmaceuticals Inc (NRPH) | 22-Nov-05 | Option Exercise Duplicate | 2,000 | $2.50 | $5,000.00 | 11% 19.0K to 21.0K | |
| 22-Nov-05 6:10 PM View: | Krishnan Suma VP, Product Development | New River Pharmaceuticals Inc (NRPH) | 22-Nov-05 | Market Sale (Planned) | 3,000 | $51.34 | $154,034.00 | (16%) 19.0K to 16.0K |
